논문KCI 등재
Erratum : Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled Trial
0
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
초록
Materials and methods Before: 3. Participants “Patients who had symptoms consistent with COVID-19 with onset less than 7 days after randomization and had positive RT-PCR results within 3 days of randomization were enrolled (Figure 1).” After: 3. Participants “Patients who had symptoms consistent with COVID-19 with onset less than 7 days and positive RT-PCR results within 3 days before randomization were enrolled (Figure 1).” Figure 1 Before: 97 excluded 14 symptom onset>3 days ago After: 97 excluded 14 symptom onset>7 days ago
관련 논문AI추천
Fluvoxamine Treatment of Patients with Symptomatic COVID-19 in a Community Treatment Center: A Preliminary Result of Randomized Controlled TrialBae Seongman, Choi Sang-Ho, Chong Yong Pil, Chung Hyemin, Jung Jiwon, Kim Haein, Kim Min-Jae, Kim Sung-Han, Kim Yang Soo, Lee Sang-Oh, Park Seonghee, Seo Hyeonji, Son Ki Young, Sung Heungsup대한감염학회 · Infection and Chemotherapy2022 · 제54권 제1호Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19Sookaromdee Pathum, Wiwanitkit Viroj대한감염학회 · Infection and Chemotherapy2022 · 제54권 제2호Reply: Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19Chong Yong Pil, Seo Hyeonji대한감염학회 · Infection and Chemotherapy2022 · 제54권 제2호Erratum : Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative StudyAn Hyonggin, Ashwin A. Patkar, Han Changsu, Jeon Sang Won, Lee Seung-Hoon, Pae Chi-Un, Prakash S Masand, Shin Cheolmin대한신경정신의학회 · PSYCHIATRY INVESTIGATION2022 · 제19권 제6호Corrigendum: A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical TrialAlessandro Serretti, Ashwin A Patkar, Changsu Han, Chi-Un Pae, Laura Mandelli, Prakash S Masand, Sheng Min Wang, Soo-Jung Lee, Won-Myong Bahk대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2020 · 제18권 제4호Hydroxychloroquine, Interleukin-6 Receptor Antagonists and Corticoid Treatments of Acute COVID-19 Infection: Psychiatric Symptoms and Mental Disorders 4 Months LaterCéline Verstuyft, David Montani, Emmanuelle Corruble, Francois Radiguer, Laurent Becquemont, Matthieu Gasnier, Nicolas Noël, Romain Colle, Walid Choucha, Xavier Monnet대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제4호
이 간행물의 다른 논문 (24건)
Which is the Preferred Regimen for Non-Severe Clostridioides difficile Infection in Korea, Vancomycin or Metronidazole?Kim Jinyeong, Kim Bongyoung, 김지은, Pai Hyunjoopp. 213-219Weight Gain and Metabolic Syndrome in Human Immunodeficiency Virus Patients장현하pp. 220-235Candida auris : An Overview of the Emerging Drug-Resistant Fungal InfectionPrakash Stephanie, Sanyaolu Adekunle, Okorie Chuku, Marinkovic Aleksandra, Abbasi Abu Fahad, Mangat Jasmine, Hosein Zaheeda, Haider Nafees, Chan Jenniferpp. 236-246Expert Consensus on Measures to Promote Physical and Psychological Health among COVID-19-Related Healthcare Workers in Korea using Delphi TechniqueLee Shinwon, Park Kyung-Hwa, 정혜숙, Hong Ki Jeong, Kim Kyoung-Beom, Lee So Hee, Kwon Ki Tae, Kim Yeonjae, Noh Jin-Won, Ryoo Hyun Wook, Heo Sang Taekpp. 247-257Early Oxygen Requirement in Patients with Mild-to-Moderate COVID-19 Who Received Regdanvimab after Delta-Variant OutbreakLee Chan Mi, 박상원, 이은영pp. 258-265
